Vident Investment Advisory LLC reduced its position in shares of Aetna Inc (NYSE:AET) by 3.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,143 shares of the company’s stock after selling 791 shares during the period. Vident Investment Advisory LLC’s holdings in Aetna were worth $3,362,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Wells Fargo & Company MN grew its holdings in shares of Aetna by 4.2% during the third quarter. Wells Fargo & Company MN now owns 1,365,596 shares of the company’s stock worth $217,144,000 after purchasing an additional 54,928 shares during the last quarter. State of Tennessee Treasury Department grew its holdings in shares of Aetna by 26.3% during the second quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after purchasing an additional 116,280 shares during the last quarter. Fayez Sarofim & Co. grew its holdings in shares of Aetna by 82.8% during the third quarter. Fayez Sarofim & Co. now owns 7,427 shares of the company’s stock worth $1,181,000 after purchasing an additional 3,365 shares during the last quarter. Banque Pictet & Cie SA bought a new stake in shares of Aetna during the second quarter worth about $10,567,000. Finally, Pictet & Cie Europe SA bought a new stake in shares of Aetna during the second quarter worth about $2,269,000. Institutional investors own 88.03% of the company’s stock.
Several research firms have recently weighed in on AET. Cantor Fitzgerald restated a “neutral” rating and set a $175.00 price target on shares of Aetna in a report on Monday, October 23rd. Citigroup upped their target price on Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a report on Thursday, November 2nd. BMO Capital Markets upped their target price on Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a report on Friday, October 27th. Zacks Investment Research cut Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Finally, Argus reiterated a “buy” rating and issued a $185.00 target price (up from $165.00) on shares of Aetna in a report on Tuesday, September 12th. Twelve analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Aetna currently has a consensus rating of “Buy” and an average price target of $175.19.
In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now directly owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Shares of Aetna Inc (NYSE:AET) traded up $3.90 during trading hours on Friday, hitting $182.73. The stock had a trading volume of 4,315,773 shares, compared to its average volume of 3,977,818. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. Aetna Inc has a one year low of $116.04 and a one year high of $192.37. The firm has a market capitalization of $59,601.41, a price-to-earnings ratio of 17.90, a price-to-earnings-growth ratio of 1.67 and a beta of 0.61.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. The business had revenue of $14.99 billion during the quarter, compared to analyst estimates of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. Aetna’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.07 EPS. research analysts anticipate that Aetna Inc will post 9.78 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Thursday, January 11th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date is Wednesday, January 10th. Aetna’s payout ratio is currently 37.04%.
ILLEGAL ACTIVITY WARNING: “Aetna Inc (AET) Holdings Cut by Vident Investment Advisory LLC” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2017/12/10/aetna-inc-aet-holdings-cut-by-vident-investment-advisory-llc.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc and related companies with MarketBeat.com's FREE daily email newsletter.